ICON, Clinical Research Phase I Unit
ICON, Clinical Research Phase I Unit
Lenexa, Kansas, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination | Drug-Drug Interaction (DDI); FDC; Healthy Volunteer; Pharmacokinetics; Safety | Recruiting | Phase 1 | 2026-07-09 | NCT06733675 |